BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//InvisionCommunity Events 4.7.23//EN
METHOD:PUBLISH
CALSCALE:GREGORIAN
REFRESH-INTERVAL:PT15M
X-PUBLISHED-TTL:PT15M
X-WR-CALNAME:Community Calendar
NAME:Community Calendar
BEGIN:VTIMEZONE
TZID:Europe/London
TZURL:http://tzurl.org/zoneinfo/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T020000Z
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T020000Z
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Priorities for diagnostics and medical technology: Regulatio
	n\, supporting research and innovation\, optimising services\, and address
	ing waiting times
DTSTAMP:20220119T124205Z
SEQUENCE:0
UID:670-1-ee2a5ec9cbd1b5a75b4ec5d63ec903ec@www.pslhub.org
ORGANIZER;CN="Patient Safety Learning":noreply@pslhub.org
DESCRIPTION:\n	This Westminster Health Forum policy conference: will ex
	amine what is needed to improve diagnostic speed and outcomes.\n\n\n\n	It 
	will also be an opportunity to discuss the future outlook for medical devi
	ce regulation in the wake of Brexit\, with the MHRA having consulted on a 
	more transparent and flexible approach.\n\n\n\n	Further sessions look at s
	upporting continued research and innovation\, with the Government launchin
	g strategic and funding plans\, including investment in modernising diagno
	stics as part of wider efforts to address waiting lists.\n\n\n\n	Additiona
	l areas for discussion include:\n\n\n\n	\n		industry partnerships\n	\n	\n	
		staff recruitment and retention\n	\n	\n		learning from the response to CO
	VID-19\n	\n	\n		opportunities for driving efficiencies.\n	\n\n\n\n	Keynote
	 sessions with:\n\n\n\n	\n		Professor Sir Mark Caulfield\, Professor of Cl
	inical Pharmacology\, Queen Mary University of London\; Chief Executive 
	Officer\, Barts Life Sciences\; and former Chief Scientist\, Genomics Engl
	and\n	\n	\n		Dr Sarah Byron\, Programme Director\, Centre for Health Tech
	nology Evaluation\, NICE\n	\n	\n		Professor Louise Jones\, Chair\, Genomic
	s and Reproductive Science Specialty Advisory Committee\, Royal College of
	 Pathologists\; and Professor of Breast Pathology\, Barts Cancer Institute
	\n	\n	\n		Stephen Lee\, Director\, Diagnostics Regulation\, Association of
	 British Healthcare Industries\n	\n	\n		Professor Michael Messenger\, Prin
	cipal Scientific Advisor for In Vitro Diagnostics\, MHRA\n	\n	\n		Doris-An
	n Williams\, Chief Executive\, British In Vitro Diagnostics Association\n	
	\n\n\n\n	Register\n\n
DTSTART;VALUE=DATE:20220301
END:VEVENT
END:VCALENDAR